Cargando…

Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy

Detalles Bibliográficos
Autores principales:	Palacios, R, González-Correa, JA, Ruiz, J, Nuño, E, Márquez, M, de la Cruz, JP, Santos, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113068/ http://dx.doi.org/10.1186/1758-2652-13-S4-P63

Ejemplares similares

Role of platelet activation in the cardiovascular complications associated with HIV infection: differential effect of abacavir versus tenofovir
por: Francisci, D, et al.
Publicado: (2010)

Abacavir forms novel cross-linking abacavir protein adducts in patients
por: Meng, Xiaoli, et al.
Publicado: (2014)

SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients
por: Kumar, P, et al.
Publicado: (2010)

Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients
por: Puerta, S, et al.
Publicado: (2010)

Tolerance and durability of abacavir/lamivudine (ABC/3TC)-containing regimens: results from a large prospective French cohort
por: Cuzin, L, et al.
Publicado: (2010)

876. Renal Function, Lipid Profile, and Cardiovascular Events After Switching to Abacavir Containing Regimen in Antiretroviral-Therapy-Experienced People Living with HIV in Northern Thailand
por: Phudphong, Pitchaporn, et al.
Publicado: (2021)

Abacavir antiretroviral therapy and indices of subclinical vascular disease in persons with HIV
por: Martinez, Claudia A., et al.
Publicado: (2022)

Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children
por: Gitta, PK, et al.
Publicado: (2010)

Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
por: Bhatti, L, et al.
Publicado: (2010)

Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals
por: Pereira, A, et al.
Publicado: (2010)

Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study
por: Martínez, E, et al.
Publicado: (2010)

Evaluation of a pharmacogenetic test in Thailand for abacavir hypersensitivity screening in human immunodeficiency virus infection
por: Chonlaphat, Sukasem, et al.
Publicado: (2014)

Molecular epidemiology of antiretroviral resistance in therapy-experienced HIV-1 patients in Cuba (2009)
por: Pérez, L, et al.
Publicado: (2010)

Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
por: Gaytán-Martínez, JE, et al.
Publicado: (2010)

Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in Australia
por: Bloch, M, et al.
Publicado: (2010)

Hypersensitivity to antiretroviral drugs a case report
por: Sousa, Maria, et al.
Publicado: (2014)

Promoting presumptive diagnosis of severe HIV disease to increase uptake of antiretroviral therapy in HIV-infected infants
por: Chiwoko, J, et al.
Publicado: (2010)

Markers of bone turnover are elevated in patients on antiretrovirals independent of the substance used
por: Piso, RJ, et al.
Publicado: (2010)

Screening of some savannah plants for antiretroviral (ANTI-HIV) activity
por: Mukhtar, MD, et al.
Publicado: (2009)

P01-01. The blood transcriptional response to early acute HIV infection is transient and responsive to antiretroviral therapy
por: Skinner, JA, et al.
Publicado: (2009)

48 week bone marker changes with Dolutegravir (DTG) plus Abacavir/Lamivudine (ABC/3TC) vs. Tenofovir/Emtricitabine/Efavirenz (EFV/TDF/FTC): the SINGLE trial
por: Yazdanpanah, Y, et al.
Publicado: (2014)

Chemical modification of the 6'-amino cyclopropyl of abacavir eliminates HLA-B*57:01-restricted CD8+ T-cell activation without loss of antiviral activity
por: Alhaidari, Mohammad, et al.
Publicado: (2014)

Immune impairment and adaptive response in relation to antiretroviral therapy of HIV-infection
por: Kaminskiy, GD, et al.
Publicado: (2010)

Favorable outcome of pregnancy on antiretroviral treatment in a patient with HIV-infection
por: Marincu, Iosif, et al.
Publicado: (2014)

Dietary management of dyslipidemia in HIV-infected young adults in antiretroviral treatment
por: Nițescu, Maria, et al.
Publicado: (2014)

Syphilis in HIV-infected patients: predictors for serological failure and serofast state
por: Palacios, R, et al.
Publicado: (2012)

Antiviral efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV-infected children and adolescents: a systematic review protocol
por: Adetokunboh, Olatunji O, et al.
Publicado: (2014)

Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis
por: Adetokunboh, Olatunji O., et al.
Publicado: (2015)

Use of antiretroviral therapy during pregnancy among HIV-infected women attending an urban care centre
por: Ssewankambo, F, et al.
Publicado: (2010)

HIV-infected patients in the ICU in the current era of high-activity antiretroviral treatment
por: Cortés, P Vidal, et al.
Publicado: (2011)

Antiretroviral therapy targeting HIV-1 viral infectivity factor; in silico approach
por: Karau, Muriira G, et al.
Publicado: (2009)

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
por: Bîstrițchi, Ina, et al.
Publicado: (2013)

Antiretroviral strategies for the treatment of pregnant HIV+ women and prevention of perinatal HIV transmission in Dodoma, Tanzania: AMANI Study
por: Liuzzi, G, et al.
Publicado: (2010)

Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy
por: Franceschi, S, et al.
Publicado: (2009)

Feasibility and effectiveness of combination antiretroviral therapy in HIV-infected infants in Pietermaritzburg, South Africa
por: Van der Linden, D, et al.
Publicado: (2010)

Services integration for injection drug users on antiretroviral therapy for management of HIV epidemic in Estonia
por: Laisaar, Kaja-Triin, et al.
Publicado: (2010)

Multicentric Castleman’s disease in HIV/AIDS patients at an urban HIV clinic in Atlanta, Georgia, in the combined antiretroviral therapy era
por: Pillai, Rathi N, et al.
Publicado: (2012)

Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
por: Broder, MS, et al.
Publicado: (2010)

Antiretroviral treatment and expression of the mRNA levels for Pgp, MRP1, MRP4 and MRP5 in HIV antiretroviral naïve patients. Follow-up at 48 weeks
por: Falasca, Francesca, et al.
Publicado: (2010)

Detection of low frequency drug resistant mutations in antiretroviral-treated HIV-1C infections
por: Okatch, Harriet, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_1m9sm2lr6h2km3e5v0aj5udd25